Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study

This study observed the antibody response and adverse events of AZD1222 (Oxford/AstraZeneca) vaccination in dialysis patients. A prospective cohort study was conducted in E-Da Healthcare Group hospitals between 1 July and 30 November 2021. Patients receiving hemodialysis (HD, n = 204) or peritoneal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hsi-Hao, Wu, Jia-Ling, Chang, Min-Yu, Wu, Hsin-Mian, Ho, Li-Chun, Chi, Po-Jui, Wu, Ching-Fang, Lee, Wan-Chia, Liou, Hung-Hsiang, Hung, Shih-Yuan, Lee, Yi-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501178/
https://www.ncbi.nlm.nih.gov/pubmed/36146538
http://dx.doi.org/10.3390/vaccines10091460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501178/
https://www.ncbi.nlm.nih.gov/pubmed/36146538
http://dx.doi.org/10.3390/vaccines10091460

Ejemplares similares